Downregulation of CDKL1 suppresses neuroblastoma cell proliferation, migration and invasion
- PMID: 30891073
- PMCID: PMC6407201
- DOI: 10.1186/s11658-019-0139-z
Downregulation of CDKL1 suppresses neuroblastoma cell proliferation, migration and invasion
Retraction in
-
Retraction Note: Downregulation of CDKL1 suppresses neuroblastoma cell proliferation, migration and invasion.Cell Mol Biol Lett. 2025 Feb 7;30(1):19. doi: 10.1186/s11658-025-00698-7. Cell Mol Biol Lett. 2025. PMID: 39920590 Free PMC article. No abstract available.
Abstract
Background: Cyclin-dependent kinase-like 1 (CDKL1) is a member of the cell division control protein 2-related serine-threonine protein kinase family. It is known to occur in various malignant tumors, but its role in neuroblastoma (NB) remains unclear.
Methods: We constructed a CDKL1-silenced NB cell strain (SH-SY5Y) and used real-time PCR and western blotting to confirm the silencing. Functional analyses were performed using the MTT, colony-formation, FACS, wound-healing and transwell invasion assays.
Results: The expression of CDKL1 was significantly upregulated in NB tissue as compared to the adjacent normal tissue. CDKL1 knockdown significantly suppressed cell viability and colony formation ability. It also induced cell cycle G0/G1 phase arrest and apoptosis, and suppressed the migration and invasion ability of SH-SY5Y cells. CDKL1 knockdown decreased the CDK4, cyclin D1 and vimentin expression levels, and increased the caspase-3, PARP and E-cadherin expression levels in SH-SY5Y cells.
Conclusions: Our findings suggest that CDKL1 plays an important role in NB cell proliferation, migration and invasion. It might serve as a potential target for NB therapy.
Keywords: CDKL1; Invasion; Migration; Neuroblastoma; Proliferation; SH-SY5Y.
Conflict of interest statement
All the clinical specimens were collected in accordance to the Declaration of Helsinki. This study was approved by the Research Ethics Committee of the Eye Hospital of the China Academy of Chinese Medical Sciences (EHCAC-20170635, date: 2017-6-12).Not applicable.The authors declare that they have no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
